The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27933950 |
304 |
Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. |
Actelion Pharmaceuticals |
27579577 |
91 |
Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers. |
Actelion Pharmaceuticals |
24900239 |
7 |
Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents. |
TBA |
21316226 |
12 |
Pyridyl amides as potent inhibitors of T-type calcium channels. |
Merck Research Laboratories |
21126876 |
16 |
Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers. |
Institute of Science and Technology |
20659804 |
19 |
Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity. |
Ewha Womans University |
18817368 |
57 |
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels. |
Merck Research Laboratories |
32327350 |
38 |
Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers. |
Kyung Hee University |
29116786 |
265 |
Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies. |
Idorsia Pharmaceuticals |
29074257 |
115 |
Discovery and evaluation of Ca |
Idorsia Pharmaceuticals |
29066309 |
87 |
Discovery and evaluation of Ca |
Idorsia Pharmaceuticals |